A team from Pusan National University, led by Associate Professor Giltae Song, has developed a new artificial intelligence model called …
Lokavant has launched Spectrum v15, an AI-powered clinical trial forecasting platform designed to reduce uncertainty in feasibility planning and enrollment …
BlackfinBio, a UK-based gene therapy company, has received FDA clearance to begin a Phase 1/2 trial of its AAV-based candidate …
A real-world study published in Nature Communications Medicine has reported that 91.5 percent of tinnitus patients experienced a clinically meaningful …
NeoGenomics has partnered with Ultima Genomics to integrate the UG 100 sequencing platform into its Cambridge, UK innovation center, aiming …
Molecular Devices has introduced the QPix FLEX Microbial Colony Picking System, a compact, automated platform for microbial colony screening. The …
Atropos Health has integrated data from Ontada, a McKesson company focused on community oncology, into the Atropos Evidence Network. The …
Deep Genomics has introduced REPRESS, a deep learning model trained to predict microRNA (miRNA) binding and mRNA degradation directly from …
Datavant has announced its acquisition of Aetion, a real-world evidence (RWE) platform used by regulators and biopharma companies to assess …
The Dementia Discovery Fund (DDF), managed by SV Health Investors, has closed its second fund, DDF-2, at $269 million, bringing …
A consortium of researchers led by the Allen Institute, with collaborators from over two dozen U.S. institutions including Harvard, Broad, …
Phesi has released a new analysis based on 167 million patient records processed via its Trial Accelerator platform, highlighting substantial …
